Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib in Fanconi Anemia Patients With Advanced HNSCC
NCT06648096Phase 2Recruiting
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Nov 2024
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of afatinib in head and neck squamous cell carcinoma (HNSCC), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Started Nov 2024; status: recruiting.
02
Drugs
afatinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT06648096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06648096.